Guthrie Clinic, Ltd.
Sayre, Pennsylvania 18840
0 studies enrolling now · 15 studies all time
What they study most
Atrial Fibrillation, Atrial Flutter, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Heart Failure, Colorectal Cancer (CRC), Congestive Heart Failure, Diabetes, Gastroesophageal Reflux Disease, Human Immunodeficiency Virus, Inflammatory Bowel Disease, Lymphoma, Non-Hodgkin
Studies at this site
- Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
- Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed
- Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry — Completed
- Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC — Completed
- Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study — Completed
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer — Completed
- Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer — Completed
- Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer — Completed
- Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer — Stopped early
- A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas — Completed
- Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg — Completed
- EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
- Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients — Completed